IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of duplicate share certificates by the Company01-08-2020
01-08-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Fixes Book Closure for AGM
IOL Chemicals & Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 19, 2020 to September 26, 2020 (both days inclusive) for the purpose of 33rd Annual General Meeting (AGM) of the Company to be held on September 26, 2020.01-08-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
IOL Chemicals and Pharmaceuticals Ltd reports strong performance in Q1' FY21 Set up another Unit-VII to manufacture Metformin with additional capacity of 7200 MT per annum resulting to total installed capacity of 11,200 MT per annum31-07-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates31-07-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Statement Of Deviation Or Variation
Statement of Deviation or Variation for proceeds of warrants issued on preferential basis and upon conversion thereof.31-07-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Outcome Of The Board Meeting Dated 31St July 2020 And Submission Of Audited Financial Results For The Quarter Ended 30Th June 2020.
Pursuant to Regulations 30 & 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held today i.e. 31st July 2020 has interalia considered the following: 1. Approved the Audited Financial Results for the Quarter ended 30th June 2020. Copy of the said financial results along with unmodified Auditors Report thereon is enclosed herewith. 2. Successful setting up a new Unit VII for manufacturing of 'Metformin' with the additional capacity of 7,200 MT per annum with capex of ? 28 Crore which is funded fully through internal accruals. Presently, the Company is operating existing unit for Metformin, having installed capacity of 4,000 MT per annum, which is fully utilized. With this additional capacity, now the total installed capacity of Metformin is 11,200 MT per annum.31-07-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Outcome Of The Board Meeting Dated 31St July 2020 And Submission Of Audited Financial Results For The Quarter Ended 30Th June 2020.
We wish to inform you that the Board of Directors in its meeting held today i.e. 31st July 2020 has interalia considered the following: 1. Approved the Audited Financial Results for the Quarter ended 30th June 2020. Copy of the said financial results along with unmodified Auditors Report thereon is enclosed herewith. 2. Successful setting up a new Unit VII for manufacturing of 'Metformin' with the additional capacity of 7,200 MT per annum with capex of ? 28 Crore which is funded fully through internal accruals. Presently, the Company is operating existing unit for Metformin, having installed capacity of 4,000 MT per annum, which is fully utilized. With this additional capacity, now the total installed capacity of Metformin is 11,200 MT per annum.31-07-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificate/issue of duplicate share certificate29-07-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice published in "Financial Express" and "Punjabi Jagran" on 23rd July 2020, regarding Board Meeting of the Company scheduled to be held on 31st July 2020.23-07-2020
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates23-07-2020